Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
22 participants
INTERVENTIONAL
2019-06-06
2022-08-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In this small pilot study, a subgroup of participants will be randomized to two cohorts, continuous walking and interval walking. Tolerability of the varied walking intensity will be measured.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
RTLS for Healthcare Process Validation
NCT04116957
RTLS Technology Study
NCT04114110
Evaluation and Implementation of Mobile Tracking Devices to Increase Safety in Hospitalized Patients (MONITOR)
NCT05418881
Feasibility of a New Ambulatory Multi-vital Signs Monitor
NCT05562011
Continuous Wireless Monitoring of Vital Signs and Automated Alerts in Participants at Home and During Hospitalization
NCT05378139
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Continuous Ambulation
The total distance will be 40 meters. Study team members will walk, support, and coach the subject to walk as slow as he/she wants
Ambulation
Variation in ambulatory intensity.
Interval Ambulation
The subject will walk a total distance of 40 meters. This distance will be divided into four intervals of 10 meters to equal the same measured distance as the continuous group. The subject will receive two minutes of rest between each interval and will be supported and coached to walk as fast as they can.
Ambulation
Variation in ambulatory intensity.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ambulation
Variation in ambulatory intensity.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Admitted to the Surgical Ward.
* Recovering from surgery.
* Ability to understand and the willingness to sign an Institutional Review Board-approved informed consent document.
* Ability to understand and complete the study survey instruments in English.
Exclusion Criteria
* Emergency surgical procedure.
* Anticipated discharge less than 24 hour.
* Unable to ambulate or ambulation not permitted by treating provider.
* Unable to understand and complete the study survey instruments in English.
* Post-operative complications that in the opinion of the study investigator would impair the ability of the patient to adhere to the study procedures.
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wake Forest University Health Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Comprehensive Cancer Center of Wake Forest University
Winston-Salem, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB00039439
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.